SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:54c85492-8ddc-4bb8-b145-aaca0b83926d"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:54c85492-8ddc-4bb8-b145-aaca0b83926d" > Axonal degeneration...

Axonal degeneration is mediated by necroptosis activation

Arrázola, Macarena S. (författare)
Universidad Mayor de Chile
Saquel, Cristian (författare)
Universidad Mayor de Chile
Catalán, Romina J. (författare)
Universidad Mayor de Chile
visa fler...
Barrientos, Sebastián A. (författare)
Lund University,Lunds universitet,Integrativ neurofysiologi,Forskargrupper vid Lunds universitet,Neuronano Research Center (NRC),Integrative Neurophysiology,Lund University Research Groups
Hernandez, Diego E. (författare)
Cold Spring Harbor Laboratory
Martínez, Nicolás W. (författare)
Pontifical Catholic University of Chile
Catenaccio, Alejandra (författare)
Universidad Mayor de Chile
Court, Felipe A. (författare)
Universidad Mayor de Chile
visa färre...
 (creator_code:org_t)
2019
2019
Engelska 13 s.
Ingår i: The Journal of Neuroscience. - 0270-6474. ; 39:20, s. 3832-3844
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Axonal degeneration, which contributes to functional impairment in several disorders of the nervous system, is an important target for neuroprotection. Several individual factors and subcellular events have been implicated in axonal degeneration, but researchers have so far been unable to identify an integrative signaling pathway activating this self-destructive process. Through pharmacological and genetic approaches, we tested whether necroptosis, a regulated cell-death mechanism implicated in the pathogenesis of several neurodegenerative diseases, is involved in axonal degeneration. Pharmacological inhibition of the necroptotic kinase RIPK1 using necrostatin-1 strongly delayed axonal degeneration in the peripheral nervous system and CNS of wild-type mice of either sex and protected in vitro sensory axons from degeneration after mechanical and toxic insults. These effects were also observed after genetic knock-down of RIPK3, a second key regulator of necroptosis, and the downstream effector MLKL (Mixed Lineage Kinase Domain-Like). RIPK1 inhibition prevented mitochondrial fragmentation in vitro and in vivo, a typical feature of necrotic death, and inhibition of mitochondrial fission by Mdivi also resulted in reduced axonal loss in damaged nerves. Furthermore, electrophysiological analysis demonstrated that inhibition of necroptosis delays not only the morphological degeneration of axons, but also the loss of their electrophysiological function after nerve injury. Activation of the necroptotic pathway early during injury-induced axonal degeneration was made evident by increased phosphorylation of the downstream effector MLKL. Our results demonstrate that axonal degeneration proceeds by necroptosis, thus defining a novel mechanistic framework in the axonal degenerative cascade for therapeutic interventions in a wide variety of conditions that lead to neuronal loss and functional impairment.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

Axonal degeneration
Mitochondrial fragmentation
MLKL
Necroptosis
Neurodegeneration
RIP kinase

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy